Risk and Protective Factors for Relapse to Alcohol Use in Patients With Liver Disease Undergoing Liver Transplantation

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

This is an observational, monocentric study, consisting of both a retrospective and a prospective component. The aim of the study is to identify risk and protective factors for alcohol relapse in patients with alcohol-related liver disease (ARLD) who have undergone orthotopic liver transplantation (OLT).

Eligibility criteria

Qualifiers

Patients who have signed the informed consent

Candidates for liver transplantation due to liver disease with alcohol-related etiology (either mono- or multifactorial)

For the retrospective part: patients who underwent OLT for ARLD during the time frame 2017-2022

Disqualifiers

Major psychopathologies and active psychoses

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed